Friday, 29 March 2019

Reuters Health Report: Shares in Galapagos jump 15 percent after arthritis drug results

Reuters.com Newsletter

Shares in Galapagos jump 15 percent after arthritis drug results

Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib.

Cholera cases jump to 138 in Mozambique's Beira after cyclone

The number of confirmed cases of cholera in the cyclone-hit Mozambican port city of Beira jumped from five to 138 on Friday, as government and aid agencies battled to contain the spread of disease among the tens of thousands of victims of the storm.

AstraZeneca in cancer drug deal that could pay Daiichi Sankyo up to $6.9 billion

AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as $6.9 billion to its Japanese partner.

U.S judge strikes down rule allowing 'skimpy' health insurance plans

A federal judge on Thursday stuck down a Trump administration rule aimed at enabling millions of Americans to buy skimpy health insurance plans that do not comply with key Affordable Care Act requirements - part of administration efforts to chip away at the healthcare law.

Bayer shares sag after U.S. jury verdict in Roundup cancer trial

Bayer AG shares sank to their lowest in almost seven years on Thursday after a U.S. jury awarded $80 million to a man who claimed use of the group's weed killer Roundup caused his cancer, with thousands of similar lawsuits looming.

Exclusive: Magellan Health nears board deal with hedge fund Starboard Value - sources

U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc is nearing an agreement with Starboard Value LP to expand the size of its board by several seats, including a representative from the activist hedge fund, three sources familiar with the matter said on Thursday.

Doctors aren't offering cholesterol drugs to all eligible patients

(Reuters Health) - Roughly one-fourth of U.S. adults who fit the criteria to be on cholesterol-lowering drugs don't take them, often because doctors don't offer them or patients worry about side effects, a new study suggests.

Dermatologists and pharmacists have differing views of topical steroids

(Reuters Health) - When it comes to prescriptions for corticosteroid creams, your dermatologist and your pharmacist may not always be on the same page, a new study suggests.

Frailty before surgery tied to more complications, higher costs

(Reuters Health) - Patients who are frail before surgery are more likely to have serious complications afterward and increased costs of care, suggesting that frailty should be factored into risk calculations before surgery, researchers say.

Mozambique to start cholera vaccinations next week after cyclone

Mozambique will start a cholera vaccination campaign next week in areas ravaged by Cyclone Idai, the World Health Organisation (WHO) said on Thursday, after five confirmed cases were detected.

N.Y. accuses opioid maker Purdue of illegal fund transfers to Sacklers

Purdue Pharma LP fraudulently transferred funds to members of the wealthy Sackler family who control the OxyContin maker despite knowing it faced major liabilities that had made it already insolvent, New York's attorney general alleged on Thursday.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS